Cedar Brook Financial Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,792
Closed -$222K 19
2024
Q2
$222K Sell
1,792
-4,087
-70% -$526K 1.67% 21
2024
Q1
$776K Sell
5,879
-69
-1% -$8.51K 0.15% 156
2023
Q4
$704K Sell
5,948
-31
-0.5% -$3.22K 0.16% 148
2023
Q3
$616K Sell
5,979
-640
-10% -$69K 0.16% 143
2023
Q2
$764K Buy
6,619
+43
+0.7% +$4.88K 0.18% 126
2023
Q1
$700K Sell
6,576
-160
-2% -$17.3K 0.18% 133
2022
Q4
$747K Buy
6,736
+493
+8% +$50.4K 0.21% 124
2022
Q3
$538K Buy
6,243
+667
+12% +$59.5K 0.17% 151
2022
Q2
$508K Sell
5,576
-25
-0.4% -$2.22K 0.16% 161
2022
Q1
$460K Buy
5,601
+717
+15% +$56.5K 0.12% 195
2021
Q4
$374K Buy
4,884
+10
+0.2% +$796 0.1% 231
2021
Q3
$366K Sell
4,874
-204
-4% -$15.5K 0.11% 213
2021
Q2
$395K Buy
5,078
+79
+2% +$5.88K 0.11% 211
2021
Q1
$368K Sell
4,999
-330
-6% -$24.3K 0.13% 187
2020
Q4
$416K Buy
5,329
+89
+2% +$6.81K 0.15% 165
2020
Q3
$415K Buy
5,240
+278
+6% +$21.8K 0.16% 159
2020
Q2
$366K Buy
4,962
+447
+10% +$33.7K 0.16% 164
2020
Q1
$331K Sell
4,515
-513
-10% -$40.3K 0.18% 159
2019
Q4
$436K Buy
5,028
+405
+9% +$33.3K 0.19% 150
2019
Q3
$371K Buy
4,623
+288
+7% +$23.1K 0.16% 180
2019
Q2
$347K Sell
4,335
-138
-3% -$10.6K 0.16% 184
2019
Q1
$355K Buy
4,473
+257
+6% +$19.2K 0.17% 178
2018
Q4
$307K Buy
+4,216
New +$298K 0.19% 170

Other funds holding MRK

Cedar Brook Financial Partners's MRK Position: Q3 2024 in Review

Cedar Brook Financial Partners sold out of Merck (MRK) in Q3 2024, closing a stake of 1,792 shares — an estimated $222K sold.

Cedar Brook Financial Partners first reported a position in MRK in Q4 2018 and held it in 23 quarters. The position peaked at $776K in Q1 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Cedar Brook Financial Partners reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 1,792 Merck shares in Q3 2024, an estimated $222K.
  • Cedar Brook Financial Partners first reported a position in Merck in Q4 2018 and held it in 23 quarters.
  • Cedar Brook Financial Partners's Merck position peaked at $776K in Q1 2024.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Cedar Brook Financial Partners's 13F filing for Q3 2024, filed 21 Oct 2024.